
Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials
Carlson, Julie A., Reddy, Krishna, Gaspar, Laurie E., Ney, Douglas, Kavanagh, Brian D., Damek, Denise, Lillehei, Kevin, Chen, ChanghuVolume:
123
Langue:
english
Journal:
Journal of Neuro-Oncology
DOI:
10.1007/s11060-015-1791-4
Date:
June, 2015
Fichier:
PDF, 535 KB
english, 2015